Up-regulation of ACE2 in remodeled left ventricles may explain worse COVID-19 outcomes in patients with underlying myocardial disorders, suggesting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
May explain worse COVID-19 outcomes in myocardial disease; leaves open ACE2/ITGA5 as therapeutic targets.
Using serial analysis of myocardial gene expression employing endomyocardial biopsy starting material in a dilated cardiomyopathy cohort, we show that mRNA expression of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) cardiac myocyte receptor ACE2 is up-regulated with remodeling and with reverse remodeling down-regulates into the normal range. The proteases responsible for virus-cell membrane fusion were expressed but not regulated with remodeling. In addition, a new candidate for SARS-CoV-2 cell binding and entry was identified, the integrin encoded by ITGA5. Up-regulation in ACE2 in remodeled left ventricles may explain worse outcomes in patients with coronavirus disease 2019 who have underlying myocardial disorders, and counteracting ACE2 up-regulation is a possible therapeutic approach to minimizing cardiac damage.
No takes yet. Share an insight, caveat, or question.
Bristow et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: